Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemiaDavide Rossi, Gianluca Gaïdano, Lodovico Terzi-di-Bergamo et al.|Blood|2015Cited by 215
Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA studyGiuseppe Rossi, Wilma Barcellini, Mirko Farina et al.|Blood|2018Cited by 89
Efficacy of recombinant erythropoietin in autoimmune haemolytic anaemia: a multicentre international studyBruno Fattizzo, Wilma Barcellini, Marc Michel et al.|Haematologica|2020Cited by 66